Win-Partners Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year Ending March 31, 2024
August 07, 2023 at 02:00 am EDT
Share
WIN-Partners Co., Ltd. provided consolidated earnings guidance for the first half and full year ending March 31, 2024. For the first half, the company expects net sales of ¥35,100 million, an Operating profit of ¥1,030 million, profit attributable to owners of the parent of ¥700 million or ¥24.63 basic per share.
For the full year, the company expects net sales of ¥75,500 million, an Operating profit of ¥2,830 million, Profit attributable to owners of the parent of ¥1,930 million or ¥67.91 basic per share.
WIN-Partners Co., Ltd. is a Japan-based company primarily engaged in the medical equipment supply business through its subsidiaries. The Company is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.
WIN-PARTNERS CO., LTD. 
